Author:
Hernandez Inmaculada,Zhang Yuting,Saba Samir
Subject
Cardiology and Cardiovascular Medicine
Reference25 articles.
1. Comparing stroke and bleeding with rivaroxaban and dabigatran in atrial fibrillation: analysis of the US Medicare part D data;Hernandez;Am J Cardiovasc Drugs,2017
2. Thromboembolic, bleeding, and mortality risks of rivaroxaban and dabigatran in Asians with nonvalvular atrial fibrillation;Chan;J Am Coll Cardiol,2016
3. Direct comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in nonvalvular atrial fibrillation;Noseworthy;Chest,2016
4. Stroke, bleeding, and mortality risks in elderly Medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation;Graham;JAMA Intern Med,2016
5. Risk of bleeding with dabigatran in atrial fibrillation;Hernandez;JAMA Intern Med,2015
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献